Biotechnology Cancer Cures Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Biotechnology Cancer Cures

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote ()	4/13/1999 6:48:00 PM
From: Mike McFarland	Read Replies (1) of 226

Jefferson Scientists FInd Further Proof Of Damage To The FHIT Gene In Breast Cancers eurekalert.org University Of Pittsburgh Cancer Institute Team Is The First To Uncover Role Of Faulty DNA Repair In Breast Cancer eurekalert.org So what pops into my head ...wild-type p53 for DNA repair... Onyx Gizzmo also misc... Ligand>Targretin Genetic Therapy>MDR-1 gene plus retroviral vector Biomira>several Corixa>vaccine Myriad>gene patents Any other ideas out there to explore? Here is a MSNBC article about Herceptin msnbc.com That is HER-2 (receptor?) What about EGF receptor Sugen ImClone Have I put anybody in the wrong slot?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next